Related references
Note: Only part of the references are listed.The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease
Marti Colom-Cadena et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Towards a treatment for genetic prion disease: trials and biomarkers
Sonia M. Vallabh et al.
LANCET NEUROLOGY (2020)
Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases
Anna Villar-Pique et al.
MOLECULAR NEUROBIOLOGY (2019)
Early neurophysiological biomarkers and spinal cord pathology in inherited prion disease
Peter Rudge et al.
BRAIN (2019)
CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD
Kaj Blennow et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Targeting Huntingtin Expression in Patients with Huntington's Disease
Sarah J. Tabrizi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development
Sonia M. Vallabh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Association of Blood and Cerebrospinal Fluid Tau Level and Other Biomarkers With Survival Time in Sporadic Creutzfeldt-Jakob Disease
Adam M. Staffaroni et al.
JAMA NEUROLOGY (2019)
The REDCap consortium: Building an international community of software platform partners
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2019)
Age at onset in genetic prion disease and the design of preventive clinical trials
Eric Vallabh Minikel et al.
NEUROLOGY (2019)
Domain-specific Quantification of Prion Protein in Cerebrospinal Fluid by Targeted Mass Spectrometry
Eric Vallabh Minikel et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia
Samir Abu-Rumeileh et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Antisense oligonucleotides extend survival of prion-infected mice
Gregory J. Raymond et al.
JCI INSIGHT (2019)
Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression
Andrew Geoffrey Bourne Thompson et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Cerebrospinal Fluid Prion Disease Biomarkers in Pre-clinical and Clinical Naturally Occurring Scrapie
Franc Llorens et al.
MOLECULAR NEUROBIOLOGY (2018)
The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease
Bianca A. Trombetta et al.
PLOS ONE (2018)
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation
Lorenzo Gaetani et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias
Samir Abu-Rumeileh et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Longitudinal brain magnetic resonance imaging and real-time quaking induced conversion analysis in presymptomatic Creutzfeldt-Jakob disease
G. Novi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature
Leonel T. Takada et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2017)
Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants
Samir Abu Rumeileh et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology-based cohort
G. G. Kovacs et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
Niklas Mattsson et al.
JAMA NEUROLOGY (2017)
Learning classification models of cognitive conditions from subtle behaviors in the digital Clock Drawing Test
William Souillard-Mandar et al.
MACHINE LEARNING (2016)
Towards authentic transgenic mouse models of heritable PrP prion diseases
Joel C. Watts et al.
ACTA NEUROPATHOLOGICA (2016)
Long-Term Preclinical Magnetic Resonance Imaging Alterations in Sporadic Creutzfeldt-Jakob Disease
Gianluigi Zanusso et al.
ANNALS OF NEUROLOGY (2016)
MRI abnormalities found 1 year prior to symptom onset in a case of Creutzfeldt-Jakob disease
Federico Verde et al.
JOURNAL OF NEUROLOGY (2016)
Quantifying prion disease penetrance using large population control cohorts
Eric Vallabh Minikel et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
Magnus Gisslen et al.
EBIOMEDICINE (2016)
Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease
Petra Steinacker et al.
SCIENTIFIC REPORTS (2016)
Rapid and Sensitive RT-QuIC Detection of Human Creutzfeldt-Jakob Disease Using Cerebrospinal Fluid
Christina D. Orru et al.
MBIO (2015)
Bank Vole Prion Protein As an Apparently Universal Substrate for RT-QuIC-Based Detection and Discrimination of Prion Strains
Christina D. Orru et al.
PLOS PATHOGENS (2015)
Association of Cerebrospinal Fluid Prion Protein Levels and the Distinction Between Alzheimer Disease and Creutzfeldt-Jakob Disease
Aline Dorey et al.
JAMA NEUROLOGY (2015)
Familial Creutzfeldt-Jakob disease with the E200K mutation: longitudinal neuroimaging from asymptomatic to symptomatic CJD
Oren S. Cohen et al.
JOURNAL OF NEUROLOGY (2015)
Predictive testing for inherited prion disease: report of 22 years experience
Jane Owen et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2014)
Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial
Stephane Haik et al.
LANCET NEUROLOGY (2014)
Huntington disease: natural history, biomarkers and prospects for therapeutics
Christopher A. Ross et al.
NATURE REVIEWS NEUROLOGY (2014)
The Evolution of Preclinical Alzheimer's Disease: Implications for Prevention Trials
Reisa Sperling et al.
NEURON (2014)
The Medical Research Council Prion Disease Rating Scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies
Andrew G. B. Thompson et al.
BRAIN (2013)
Cognition assessment using the NIH Toolbox
Sandra Weintraub et al.
NEUROLOGY (2013)
Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease
Michael D. Geschwind et al.
NEUROLOGY (2013)
Early Detection of Abnormal Prion Protein in Genetic Human Prion Diseases Now Possible Using Real-Time QUIC Assay
Kazunori Sano et al.
PLOS ONE (2013)
Time Course of Prion Seeding Activity in Cerebrospinal Fluid of Scrapie-Infected Hamsters after Intratongue and Intracerebral Inoculations
Christina D. Orru et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Early detection of familial Creutzfeldt-jakob disease on diffusion-weighted imaging before symptom onset
Yuka Terasawa et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Age and diagnostic performance of Alzheimer disease CSF biomarkers
N. Mattsson et al.
NEUROLOGY (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The measurement of everyday cognition: Development and validation of a short form of the Everyday Cognition scales
Sarah Tomaszewski Farias et al.
ALZHEIMERS & DEMENTIA (2011)
Early detection of sporadic CJD by diffusion-weighted MRI before the onset of symptoms
Katsuya Satoh et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
A systems approach to prion disease
Daehee Hwang et al.
MOLECULAR SYSTEMS BIOLOGY (2009)
Spontaneous Generation of Prion Infectivity in Fatal Familial Insomnia Knockin Mice
Walker S. Jackson et al.
NEURON (2009)
Measuring prions by bioluminescence imaging
Gueltekin Tamgueney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results
Christopher G. Goetz et al.
MOVEMENT DISORDERS (2008)
The measurement of Everyday Cognition (ECog): Scale development and psychometric properties
Sarah Tomaszewski Farias et al.
NEUROPSYCHOLOGY (2008)
Pre-symptomatic diagnosis in fatal familial insomnia:: serial neurophysiological and 18FDG-PET studies
P Cortelli et al.
BRAIN (2006)
Examination of the utility of the Beck Anxiety Inventory and its factors as a screener for anxiety disorders
OT Leyfer et al.
JOURNAL OF ANXIETY DISORDERS (2006)
Test review: Delis-Kaplan executive function system
S Homack et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2005)
The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment
ZS Nasreddine et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies
M Pocchiari et al.
BRAIN (2004)
Share Paper
